Kia recalled over 70,000 Sorento model vehicles because of an issue with the headlights and taillights. This recall covers certain 2024-2025 Sorento cars. Kia issued a recall of 74,469 Sorento model ...

Bernstein analyst William Pickering maintained a Buy rating on Beam Therapeutics (BEAM – Research Report) today and set a price target of $37.00. The company’s shares closed yesterday at $25.54.

More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients and Present Updated Data by Mid-2025 Initial Data from Phase 1/2 Trial of ...

Cambridge, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced progress ...

Cambridge, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced ...

NASA's Parker Solar Probe has beamed home its first detailed update eight days after making a record-breaking approach to the sun, the agency announced. The spacecraft confirmed its systems and ...